2.86
  Price1.42%   +0.0400
(After Hours: 2.88 +0.0200 +0.70%)
Jun-06-22 10:20AM Why Altria Should Sit on Its 10% Stake in Anheuser-BuschThe Motley Fool
May-30-22 08:35AM Sundial Growers' CEO Says There's "A Reckoning Taking Hold" in Cannabis. He's Right.The Motley Fool
May-11-22 01:00AM Cronos Group Inc. (CRON) Q1 2022 Earnings Call TranscriptThe Motley Fool
May-10-22 04:15AM Cronos Group Inc. Announces Conference Participation for May 2022GlobeNewswire Inc.
03:34AM Why Cronos Group Stock Soared 13.8% TodayThe Motley Fool
May-10-22 08:45AM Cronos Group (CRON) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research
May-01-22 07:59AM Altria Shows Once Again Why Tobacco Is a Great Defensive StockThe Motley Fool
Apr-29-22 10:00AM Cronos Group Inc. to Hold Virtual 2022 Annual Meeting of ShareholdersGlobeNewswire Inc.
Apr-25-22 04:30AM Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022GlobeNewswire Inc.
Apr-21-22 10:17AM Love Passive Income? These Dividend Stocks Are for YouThe Motley Fool
08:40AM Leafly CEO rings Nasdaq bell on cannabis holidayMarketWatch
Apr-21-22 12:43PM 4 Charts: Cannabis Stocks Gone To PotInvesting.com
Apr-20-22 01:22AM Leafly CEO rings Nasdaq bell on cannabis holidayMarketWatch
09:00AM A New Fund For 4/20: Here Are The Details Of The Roundhill Cannabis ETFBenzinga
Apr-11-22 08:01AM Urban-gro eyes 80% revenue growth as indoor farm specialistMarketWatch
Mar-29-22 01:11AM New Jersey Senate To Examine Cannabis Rollout Delays, Marijuana Companies, Advocates Grow IrritatedBenzinga
Mar-28-22 01:01AM These 7 Cannabis Stocks May Be Underappreciated As Market Continues To ReboundBenzinga
Mar-25-22 07:11AM Cannabis stocks rally on flurry of federal moves toward legalizationMarketWatch
Mar-24-22 04:55AM Will The Cannabis Legalization Bill Affect Penny Stocks? 3 to Watch PennyStocks
04:10AM Cannabis Stocks That Moved On News Federal Legalization Bill Is Heading To House For Vote Next WeekBenzinga
Mar-22-22 10:03AM Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022Benzinga
Mar-21-22 07:30AM Cronos Group Founder Mike Gorenstein Returns as CEOGlobeNewswire Inc.
Mar-17-22 08:12AM 3 Growth Stocks That Could Be Headed for TroubleThe Motley Fool
Mar-11-22 07:28AM Is Cronos a Buy After Reporting 51% Sales Growth in Q4?The Motley Fool
Mar-10-22 04:27AM Death Rattles: 18 Companies Hitting New LowsInvesting.com
Mar-07-22 09:28AM Analyst Ratings For Cronos GroupBenzinga
Mar-02-22 07:49AM Green Thumb CEO eyes 'wonderfully boring' execution of new market growth planMarketWatch
Mar-01-22 07:41AM Cronos Group Still Struggles As Grower Awaits U.S. Cannabis LegalizationInvesting.com
07:30AM Cronos Group Reports 2021 Fourth Quarter and Full-Year ResultsGlobeNewswire Inc.
Mar-01-22 06:45AM The Smartest Stocks to Buy With $700 Right NowThe Motley Fool
Feb-25-22 03:00AM Cronos Group Inc. to Hold 2021 Fourth Quarter and Full-Year Earnings Conference Call on March 1, 2022GlobeNewswire Inc.
Feb-24-22 11:15AM 2 Growth Stocks That Wall Street Thinks Can Double in ValueThe Motley Fool
Feb-22-22 07:25AM 10 Biggest Price Target Changes For TuesdayBenzinga
Feb-21-22 03:30AM Cronos Group Inc. (CRON) Q3 2021 Earnings Call TranscriptThe Motley Fool
Feb-18-22 11:15AM Is This SPAC a Buy After Falling More Than 50%?The Motley Fool
07:30AM Cronos Group Reports 2021 Third Quarter ResultsGlobeNewswire Inc.
Feb-17-22 04:30AM Cronos Group Inc. to Hold 2021 Third Quarter Earnings Conference Call on February 18, 2022GlobeNewswire Inc.
Feb-11-22 07:30AM Cronos Group Provides Bi-Weekly MCTO Status UpdateGlobeNewswire Inc.
Feb-09-22 11:45AM Canopy Growth and Aurora Cannabis are expected to generate less red ink when they report earnings this weekMarketWatch
Feb-08-22 02:39AM Canopy Growth and Aurora Cannabis are expected to generate less red ink when they report earnings this weekMarketWatch
Jan-29-22 06:26AM 2 Stocks to Avoid Like the Plague in 2022The Motley Fool
Jan-28-22 08:00AM Cronos Group Provides Bi-Weekly MCTO Status UpdateGlobeNewswire Inc.
08:29AM Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray's price targetMarketWatch
Jan-27-22 01:55AM Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray's price targetMarketWatch
Jan-25-22 05:15AM Canadian Pot Stocks Had a Disappointing Year. Will 2022 Be Better?The Motley Fool
Jan-20-22 03:28AM Cannabis Movers & Shakers: Akerna, iAnthus, Cronos Group, WSU's Cannabis Research CenterBenzinga
09:42AM Cronos Promotes John Griese, Former Exec At Nestlé, PepsiCo And Supreme CannabisBenzinga
Jan-18-22 05:36AM 4 Pot Stocks to Avoid Like the Plague in 2022The Motley Fool
Jan-14-22 04:15AM Cronos Group Provides Bi-Weekly MCTO Status UpdateGlobeNewswire Inc.
07:15AM 2 Pot Stocks To Flat Out Avoid in 2022The Motley Fool
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
Cap:    |  Volume (24h):